Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan for Ischemic Kidney Injury in Partial Nephrectomy
NCT04450095Phase 2Unknown
- Sponsor
- Bnai Zion Medical Center
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambrisentan in acute kidney injury (AKI), sponsored by Bnai Zion Medical Center. Status: unknown.
02
Drugs
ambrisentan
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04450095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04450095.